IMMUNIC, INC. (IMUX) › Operating IncomeIMMUNIC, INC. (IMUX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: -$9.58M2013: -$31.40M2014: -$50.34M2015: -$52.12M2016: -$41.27M2017: -$52.66M2018: -$12.00M2019: -$37.03M2020: -$48.97M2021: -$91.67M2022: -$119.49M2023: -$99.22M2024: -$98.05M2025: -$103.23M-$103.23M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$103.23M-5.3%2024-$98.05M+1.2%2023-$99.22M+17.0%2022-$119.49M-30.4%2021-$91.67M-87.2%2020-$48.97M-32.2%2019-$37.03M-208.7%2018-$12.00M+77.2%2017-$52.66M-27.6%2016-$41.27M+20.8%2015-$52.12M-3.5%2014-$50.34M-60.3%2013-$31.40M-227.8%2012-$9.58M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share